Summary
In a significant market movement during July 2025, Portal Biotech was the subject of a vc funding. The transaction achieved a gross valuation of £25,451,313. Leading the round was Earlybird Venture Capital, 8VC, We Venture Capital, British Business Bank, WS Investment Company, Pillar VC, SCVC, Amino Collective, Outsized Ventures, NATO Innovation Fund.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Earlybird Venture Capital
Lead Investor / Acquirer
8VC
Lead Investor / Acquirer
We Venture Capital
Lead Investor / Acquirer
British Business Bank
Lead Investor / Acquirer
WS Investment Company
Lead Investor / Acquirer
Pillar VC
Lead Investor / Acquirer
SCVC
Lead Investor / Acquirer
Amino Collective
Lead Investor / Acquirer
Outsized Ventures
Lead Investor / Acquirer
NATO Innovation Fund
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series A prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in